Merck Sharp & Dohme’s new crown drug China offer is out, cheaper than Pfizer’s and lower than other countries’ prices
As the second imported neo-crown small molecule oral drug listed in China, the first offer of Merck Sharp & Dohme Monoprevir capsules in China has...
Six new crown treatment items, including prone ventilation therapy, are reimbursable, and Hunan adjusts the price of medical services related to new crown infections
Today, the Hunan Provincial Medical Security Bureau issued a document announcing the "Notice on New and Revised Medical Service Price Items Related to New Coronavirus...
“Yang Kang” flocked to Sanya, tourism chaos also came ……
When the huge crowds come, it is also a test for the local service and management level. Recently, the tourism market has seen a long-awaited...
Multinational sources: China’s optimization of epidemic prevention and control is conducive to the development of world economic recovery
A few days ago, many countries said that China's recent measures to optimize the prevention and control of the epidemic are scientific, effective and realistic,...
Several experts suggest that future vaccinations are also needed for the new crown
A second booster dose of the New Crown vaccine is currently being promoted in multiple locations. Several experts said that the new crown vaccine can...
What should I do about the “top 10” symptoms and “four systemic” sequelae in the early stage of the new crown?
The "Ten Symptoms" of Newcastle The "ten symptoms" of NPS are fever, dry cough, fatigue, loss of smell and taste, nasal congestion, runny nose, sore...
Huahai Pharmaceuticals: is actively working with Pfizer to accelerate the localization of Paxlovid to ensure adequate supply of Paxlovid in the Chinese market
Huahai Pharmaceutical said in an interactive platform on January 10, the company is actively cooperating with Pfizer to accelerate the work of the localization project...
India’s new crown generic drug manufacturer is actually an import and export company, the Indian drug regulatory agencies official website search no such drug
On January 8, the much-anticipated Pfizer New Crown oral drug Paxlovid (nematovir tablets/ritonavir tablets) failed to enter the national medical insurance drug catalog due to...
Pfizer: allow China strong generic Paxlovid news is not true, as soon as 3 to 4 months to achieve local production in China
Whether Pfizer Paxlovid can be strongly generic in China, when it will be produced and how to secure supply, reporters obtained information from Pfizer China...
Sinopharm: Merck Sharp & Dohme’s new crown oral drug is expected to be sold before the Spring Festival, the first few hundred thousand boxes
"Optimistic estimates, Mercer's new crown oral drug Monoravir is expected to be on sale in the domestic market before the Spring Festival." On January 10,...